Response Biomedical's Q1 Sales Fall 43 Percent, Loss Increases

The firm's clinical sales fell, which it said were caused by a few factors, including a weak flu season.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories